Real World Experience Utilizing Donor Kidneys at Risk for Acute Kidney Injury with Belatacept Based Maintenance Immunosuppression
American Journal of Transplantation
; 22(Supplement 3):1087-1088, 2022.
Article
in English
| EMBASE | ID: covidwho-2063515
acute kidney failure; child; clinical assessment; cold ischemia time; conference abstract; controlled study; coronavirus disease 2019; creatinine blood level; diuresis; drug combination; drug therapy; estimated glomerular filtration rate; female; graft failure; heart death; high risk population; human; human cell; human tissue; immunosuppressive treatment; incidence; kidney graft; leukopenia; lymphocyte; major clinical study; male; mortality; nephrotoxicity; neutropenia; outcome assessment; retrospective study; surgery; viremia; belatacept; mycophenolic acid; steroid
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
American Journal of Transplantation
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS